Skip to main content

Biomedical Politics (1991) / Chapter Skim
Currently Skimming:

Index
Pages 339-352

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 339...
... ,6, 14, 23, 24-28, 29, 42,310, 318 Albert Lasker Clinical Medical Research Award, 75 Alberts, Bruce, 128-129, 130, 138, 154 Alliance for Aging Research, 152, 155 Alliance for Life, 70 ALZA Corporation, 84 Alzheimer's disease, 137
From page 340...
... D., 5-6 Barnhart, Ben, 151, 152 Barrell, Bart, 108, 111 Baulieu, Etienne-Emile, 49-50, 51, 52, 53, 58,61,62,63-64,66,75 Beadle, George W., 261-262, 286n.8 Becker, E Lovell, 191, 193 Beckman Foundation, 111 Beckwith, Jonathan, 279-280, 291n.52 Berg, Paul and Asilomar conference, 269, 272-273, 274, 275, 276, 277, 281, 282, 283, 291n.52, 313 and genome project,112,124,125,127128, 140-141, 154, 161 recombinant DNA research, 265, 266267, 268, 286n.8, 289nn.37, 38 Berkeley National Laboratory, 120-121, 131 Bioethics Board, 253, 254n.13 Biomedical Ethics Advisory Committee, 253 Biomedical research,2,3,5,157,158,259261, 287n.25 Biotechnology, 157, 158, 303, 304, 306 Biotechnology Science Coordinating Committee, 136, 284 Birth control pill, 49 controversy over, 43, 46, 48, 52, 59, 60 market for, 52, 82 Birth defects, 55, 83, 84, 95 Bitensky, Mark, 114, 115 Black, Francis, 287n.25, 306 Bleich, J
From page 341...
... , 80 Chiles, Lawton, 133, 137-138, 151, 170 China, 45, 61, 64-65, 73, 74, 76, 78 Chronic granulomatous disease, 104 Church, George, 111, 113 Civil rights movement, 309-310, 327 Clinical trials AIDS drugs, 10, 12, 15-16, 20, 23, 24, 26, 35n.1, 41 birth control pill, 48, 59 dideoxyinosine (ddI) , 10, 21-22, 26, 27, 28, 31,35,36n.11,38,39-40,42 drugs, 11, 12-14, 36n.6 fetal tissue transplantation, 234 RU-486, 46, 50, 51-52, 54, 73, 76, 80, 83, 94-95 Cohen, Stanley, 270, 271, 276, 282, 289n.38, 299 Cold Spring Harbor Laboratory, 100, 266, 267 human genome conference, 123-125, 126, 127-128, 131, 174 Collaborative Research, Inc., 108-109 Color blindness, 102 Comings, David, 115 Committee to Save Unborn Children, 61 Compassionate use, 24, 25, 38 Conable, Barber, 119, 188 Congressional Budget Office, 183, 198 Congressional Budget Reform Act (1974)
From page 342...
... AIDS activists and, 10, 15, 23, 24, 31-33, 310, 313-314, 318 Bristol-Myers and, 24-25, 27, 28-30 clinical trials, 10,21-22,26,27,28,31, 35, 36n.11,38,39-40,42 early release decision, 6, 7, 10-11, 2428,33-35,38-40,41-42,311,316317, 320 FDA and, 6, 18, 19, 20, 24, 25-26, 2728, 30, 33-34, 38, 39, 42, 313 Diethyl stilbestrol (DES) , 56 Diffusion-adoption continuum, 5-6 Dingell, John D., 132 Dinkins, David N., 80 Disease fetal tissue research and, 43, 216, 217, 234, 238 genetic, 104, 105, 150, 157 germ theory of, 262 pathogens and, 263, 278 RU-486 treatment applications, 46, 72, 77-78, 86-87 Domenici, Pete V., 118, 119-120, 133, 137, 138, 139-140, 170 Domestic Policy Council, 136 Donis-Keller, Helen, 109, 111, 129 Dor, Xavier, 57-58 Dornan, Robert, 53, 70, 77, 78, 81 Double Helix (Watson)
From page 343...
... , 11, 36n.5 Ford, Wendell H., 118 Ford Foundation, 49 France, 264, 290n.41 abortion controversy in, 62, 63 abortion law, 44, 52, 65 coercion of Roussel, 46, 65-67 contraceptive law, 49 and development of RU-486, 50, 52, 57 RU-486 approval, 60, 64-65, 69, 70, 83, 94, 98 RU-486 availability in, 43, 44, 45, 61, 68, 73, 76 Fredrickson, Donald, 111, 119, 125, 126 French Family Planning Association, 64 French Movement for Family Planning, 63 Friends of the National Library of Medicine, 143 Froelich, Edwin, 149-150 Fruit fly (Drosophila) , 171, 261, 273 Fuji Photo Film Company, Ltd., 108 Fullerton, William D., 185, 188, 190, 191, 195, 205-206n.1 Fund for the Feminist Majority, 76 Funding abortion research, 70, 72, 78, 288n.29 contraceptive research, 60 fetal tissue research, 217, 221, 228-229, 231, 232, 235, 236, 238, 256-257, 288n.29 fetal tissue research, federal funding ban, 43, 216, 218-219, 226-227, 235-238, 239-240, 288n.29 human genome project, 99, 101, 112113, 118, 119, 121, 126, 140, 141, 142-147, 171-172
From page 344...
... , 234-235 Human Gene Mapping Library (HHMI) , 126 Human genetics, 102, 104, 107, 150 Human genome project,6-7,99-102,152155, 157-159, 169-172, 173-175, 312, 313, 315 costs of, 112-113, 114, 116, 124, 140, 141, 142-145, 159-162, 163-164, 316, 319 DOE plan, 113-123, 130, 131-132, 137, 149, 155, 156, 162, 170, 173, 174 DOE plan, opposition to, 125, 127,128, 134, 136, 138, 155 ethical and social issues, 147-151, 164, 171, 174, 318 genetic linkage mapping, 103-104, 108, 111, 121-122, 123-124, 126, 127, 130, 140, 162 NIH-DOE joint project, 133, 138, 140141, 142-147, 151-152, 153, 154, 164, 170, 171 NIH plan, 108, 125, 130, 134-137, 156, 173 NRC report on, 128-31, 133, 141, 144, 145, 152, 154, 161, 170
From page 345...
... , 178, 180 Kidney transplantation, 177, 178, 182, 189 costs of, 196, 197, 204, 211 Gottschalk Committee and, 179, 181, 206n.4 Medicare coverage, 198-199,200, 205, 209-210, 212-213 King, Martin Luther, Jr., 327 Kingsbury, David, 128, 136-137 Kirschstein, Ruth, 128, 131,134, 135, 140, 141, 142, 144, 146, 147, 149-150 Kissinger, Henry A., 174 Kolff, Willem, 177, 180 Korean War, 177 Kornberg, Arthur, 286n.8 Kountz, Samuel, 193, 196, 197, 201, 206n.7 Kourilsky, Philippe, 258, 282, 284n.1 Krimsky, Sheldon, 265, 271, 292n.58 Lac operon, 279-280 Laetrile, 23, 40 Landers, Ann, 60 Lear, John, 266, 271, 289n.38 Lederberg, Joshua, 262, 278, 282, 286n.8 Leonard, Victoria, 67, 68 Levinson, Rachel, 135, 140 Lewin, Roger, 125, 126 Lewis, Andrew M., 267-268, 269, 278, 279, 287n.24 Lewis, Herman, 265, 268, 272, 274 Liability and contraceptive development,55,8384, 95 and recombinant DNA research, 281, 306 and RU486, 55-56, 81, 82, 84, 85, 86, 96 Library of Congress, 183 Lincoln, Abraham, 135 Litigation, 55, 320 Livermore National Laboratory, 120, 121
From page 346...
... , 187 National Cancer Institute (NCI) , 14, 137, 265, 268, 279, 287n.25 National Center for Biotechnology Information, 143 National Center for Human Genome Research, 100, 150, 152 National Center for Nursing Research, 150 National Committee to Review Current Procedures for Approval of New Drugs for Cancer and AIDS, 24 National Conference of Catholic Bishops, 222 National health insurance, 185, 189, 194, 202, 312 National Health Insurance Partnership Act (1971)
From page 347...
... , 218, 227 National Policy Board on the Human Genome, 137 National Research Council (NRC) , TOO, 128, 162, 273-274, 288n.31 Committee on Mapping and Sequencing the Human Genome report, 128131, 133, 141, 144, 145, 152, 154, 161, 170 National Right to Life Committee (NRLC)
From page 348...
... trials of RU-486, 46, 79, 83 Proteins, 104, 262, 271 sequencing, 106 synthesis, 105,107, 265 Psychotropic drugs, 300 Public and ESRD program, 210 and human genome project,152, 154155, 171, 174-175, 316, 317, 331 involvement in policymaking, 2, 5, 8, 309-310, 312, 315, 316, 317-318, 320, 321-322, 325-331 and recombinant DNA research, 257, 279, 280-281, 300~01, 302 307, 311 and RU-486, 45-46, 56, 60, 61, 62, 66, 71-72, 318 and scientific research, 27O, 272, 279, 30O, 306 Public Health Service (PHS) , 137, 260 and AIDS, 9-10 and early release of ddI, 16, 17-18 and fetal tissue research, 241 and human genome project, 142 and kidney disease treatment, 178, 180, 181, 201-202, 210 Public Health Service Act (1944)
From page 349...
... market, 46, 68, 73, 75, 76,78, 80,87,98 Ruddle, Francis, 114, 126, 128, 129 RU-486, 7-8, 94-96, 97-98, 316 anti-abortion opposition to, 43, 54-58, 76, 310-311, 317, 318 black market, 68 boycott threats against, 54-55, 69-71, 74, 96 commercial interest in, 51-53 corporate withdrawal of, 58-63, 76 cost of, 45, 52-53, 76 development of, 48, 49-51 efficacy, 44, 45, 50, 54, 55, 78-79, 84, 95 French government's coercion of Roussel, 63-67 industry constraints, 47, 59-60, 81-86, 317 international availability, 73-75 non-abortion treatment applications, 46, 72, 77-78, 86-87 public and, 45-46, 56, 60, 61, 62, 66, 71-72, 318 safety, 44 45, 59, 73, 81, 95 side effects, 44, 52, 54, 56, 61, 72, 77, 78, 79 U.S. market and, 6, 43, 71-73, 75-81, 86-87, 97 Sachs, Linda, 80-81 Safety contraceptives, 48 ddI, 26, 38, 39 drugs, 11, 12, 18-19, 22, 23 RU-486, 44 45, 59, 73, 81, 95 Sakiz, Edouard, 49, 50, 57-58, 59, 61, 6364, 66, 67, 73, 81 San Francisco General Hospital, 80 Sanger, Frederick, 106, 108, 111 San Jose Mercury, 109 Santa Fe Workshop, 115, 123, 124, 159, 160
From page 350...
... , 94 Science for the People, 279, 306 Scientific community and early release of ddI, 20-22, 31 and human genome project, 123-128, 154-155, 171-172, 174 and recombinant DNA, 299-300, 302, 317-318 Scientist, 112 Scorsese, Martin, 63 Scribner, gelding, 177, 180, 181,197,201, 206n.2 Scriver, Charles, 111, 125, 126 Searle, G D., & Company, 59, 60, 68-69, 83,84 Seattle Artificial Kidney Center, 181-182 Segal, Sheldon, 58, 63, 67 Seiko Instruments, Inc., 108 Sexually transmitted diseases, 9 Shatkin, Aaron J., 274, 275, 278-279 Shaw, George Bernard, 290n.44 Shultze, Charles L., 179 Shumway, Norman Edward, 193 Sickle cell anemia, 105, 150, 157 Side erects contraceptives, 84 RU486, 44, 52, 54, 66, 61, 72, 77, 78, 79 Sikorsky, Gerry, 55-56 Simian virus 40 (SV40)
From page 351...
... , 50, 86 U.S. Congress, 51 and early drug release, 17, 19, 29 and fetal tissue research, 219, 227, 235, 239-240 House Ways and Means Committee, 187-190, 19~195, 198, 213, 313 and human genome project, 6-7, 114, 117-120, 128, 130, 131, 137-138, 151, 152, 153, 154, 156, 164, 316 human genome project funding, 101, 112, 133, 139-140, 142-143, 146147, 172 and kidney disease, 179, 181 kidney disease Medicare entitlement, 176-177, 178, 182-185, 186-195, 198-199, 200-201, 202, 203, 210, 213, 315, 319 and NIH budget, 132, 135-136 and recombinant DNA research, 259 and RU-486, 47, 54, 55-56, 70, 73, 77, 78, 96 and science, 148, 260, 314-315 Senate Finance Committee, 190-194, 198, 204 U.S.
From page 352...
... 352 ~ INDEX White, Ray, 109, 113, 125-126, 128, 129 Willke, John, 53, 62, 67, 76, 85 Windom, Robert E., 216, 218, 229, 234, 243 Wolfe, Sidney, 24 Wolkstein, Irwin, 185, 191, 205-206n.1 Women abortion decision, 56, 220-221, 223, 224, 229, 230, 232-233, 235, 236, 241 abortion opponents and, 43, 57, 59, 63, 64 advocacy groups, 55, 57, 86, 87, 309310, 327 contraceptive development and, 47, 48, 55-56, 59 fetal tissue donation decision, 225, 226228, 229-230, 231, 232-233, 234, 236, 252, 253 pregnancy mortality, 71 in RU-486 studies, 44, SO, 74, 78-79, 80 RU-486 use, 45, 66, 68, 73, 75, 84, 94, 96 Women and Health, 50 Wood, Francis Aloysius, 137-138 World Congress of Gynecology and Obstetrics, 63 World Health Organization (WHO) , 51, 54, 65,71,73,83,86,94 World War II, 325, 327 Wyden, Ron, 46, 77-78, 81 Wyeth Laboratories, Inc., 52 Wyngaarden, James B., 216 and establishment of genome project, 112, 128, 12~130, 131, 142, 153, 170 and genome project funding, 134, 135136, 139-14O, 141, 141 146, 146-147 Yale University, 236 Yard, Molly, 72 Yeast, DNA mapping, 106, 109, 113, 162, 171 Young, Frank, 51 and ddI early release, 10, 13, 16, 1819, 25, 26, 27-28, SO, 32, 33-34, 36n.8 and RU-486, 73, 77 Zinder, Norton D., 151, 153, 272-273, 274 ZK 98.299, 52 ZK 98.734, 52


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.